FAMVX | PAMCX | FAMVX / PAMCX | |
Total Expense Ratio | 1.18 | 1.01 | 117% |
Annual Report Gross Expense Ratio | 1.17 | 1.01 | 116% |
Fund Existence | 39 years | 26 years | - |
Gain YTD | 5.088 | 2.341 | 217% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 2500 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.79B | 26.7B | 7% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 0.62 | -6.28 | -10% |
Returns for 3 years | 31.58 | 17.37 | 182% |
Returns for 5 years | 30.05 | -6.64 | -453% |
Returns for 10 years | 57.94 | 23.87 | 243% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVDX | 19.55 | 0.80 | +4.27% |
T-REX 2X Long NVIDIA Daily Target ETF | |||
XOVR | 21.44 | 0.33 | +1.56% |
ERShares Private-Public Crossover ETF | |||
BBP | 72.16 | 0.53 | +0.75% |
Virtus LifeSci Biotech Products ETF | |||
IJJ | 130.67 | 0.89 | +0.69% |
iShares S&P Mid-Cap 400 Value ETF | |||
RSPM | 32.94 | 0.19 | +0.58% |
Invesco S&P 500® Equal Weight Matrls ETF |